3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.
Sean E. George, insider at Invitae
Sean E. George Insider Alerts

Get notified the next time Sean E. George buys or sells Invitae stock. Enter your email address below to get our daily insider buying and selling report.

Sean E. George Insider Information

CEO of Invitae
Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

How do I contact Sean E. George?

The corporate mailing address for Dr. George and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (415) 374-7782 and via email at [email protected]

Has Sean E. George been buying or selling shares of Invitae?

Sean E. George has not been actively trading shares of Invitae during the past quarter. Most recently, Sean E. George sold 3,675 shares of the business's stock in a transaction on Tuesday, June 22nd. The shares were sold at an average price of $33.02, for a transaction totalling $121,348.50.

Who are Invitae's active insiders?

Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO).

Are insiders buying or selling shares of Invitae?

During the last year, insiders at the medical research company sold shares 31 times. They sold a total of 391,267 shares worth more than $13,307,844.77. The most recent insider tranaction occured on November, 11th when insider Robert L Nussbaum sold 29,675 shares worth more than $649,585.75. Insiders at Invitae own 1.9 % of the company.

Information on this page was last updated on 11/11/2021.

Sean E. George Insider Trading History at Invitae

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2021Sell3,675$33.02$121,348.50View SEC Filing Icon  
6/14/2021Sell21,201$31.63$670,587.63View SEC Filing Icon  
5/20/2021Sell3,675$28.00$102,900.00View SEC Filing Icon  
4/22/2021Sell3,675$36.44$133,917.00View SEC Filing Icon  
3/22/2021Sell3,675$42.61$156,591.75View SEC Filing Icon  
3/15/2021Sell27,417$42.90$1,176,189.30View SEC Filing Icon  
3/4/2021Sell3,675$36.67$134,762.25View SEC Filing Icon  
1/21/2021Sell8,675$53.80$466,715.00View SEC Filing Icon  
12/22/2020Sell3,675$53.06$194,995.50View SEC Filing Icon  
11/20/2020Sell8,683$47.98$416,610.34View SEC Filing Icon  
9/10/2020Sell742$33.87$25,131.54View SEC Filing Icon  
8/19/2020Sell15,473$32.10$496,683.30View SEC Filing Icon  
5/20/2020Sell25,500$16.70$425,850.00View SEC Filing Icon  
8/19/2019Sell16,358$25.29$413,693.82View SEC Filing Icon  
5/20/2019Sell24,282$18.21$442,175.22View SEC Filing Icon  
5/15/2018Sell20,311$6.96$141,364.56View SEC Filing Icon  
See Full Table

Sean E. George Buying and Selling Activity at Invitae

This chart shows Sean E. George's buying and selling at Invitae by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Invitae Company Overview

Invitae logo
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $11.45
Low: $11.38
High: $12.70

50 Day Range

MA: $15.90
Low: $11.16
High: $21.96

2 Week Range

Now: $11.45
Low: $10.88
High: $57.50

Volume

5,792,464 shs

Average Volume

5,505,477 shs

Market Capitalization

$2.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76
3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.